Effects of epidermal growth factor on MDA-MB-468 breast cancer cells: Alterations in polyamine biosynthesis and the expression of p21/CIP1/WAF1

Journal of Cellular Physiology

Volumn 179, Issue 3, 1999, Pages 257-266

  Thomas, Thresia ^a,b   Balabhadrapathruni, Srivani ^a   Gardner, Carol R ^c   Hong, Jianto ^d   Faaland, Carol A ^d   Thomas, T J ^d  

^a RUTGERS UNIVERSITY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSYLMETHIONINE DECARBOXYLASE; CYCLIN DEPENDENT KINASE; DNA; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ORNITHINE DECARBOXYLASE; PROTEIN P21; PUTRESCINE; SPERMIDINE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; POLYAMINE SYNTHESIS; PRIORITY JOURNAL;

BENZIMIDAZOLES; BREAST NEOPLASMS; CELL DIVISION; CYCLIN D1; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; FLUORESCENT DYES; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH INHIBITORS; HUMANS; POLYAMINES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032927809     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199906)179:3<257::AID-JCP3>3.0.CO;2-4     Document Type: Article

References (73)

1. Armstrong DK, Kaufmann SH, Ottaviano YL, Furuya Y, Buckley JA, Isaacs JT, Davidson NE. 1994. Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res 54:5280-5283.
2. Avila M, Vealsco JA, Cansado J, Notario V. 1994. Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB-468. Cancer Res 54:2424-2428.
3. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248-254.
4. Burton K. 1956. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315-323.
5. Carpenter G, Cohen S. 1990. Epidermal growth factor. J Biol Chem 265:7709-7712.
6. 12-bis(ethyl)spermine in human lung cancer cell lines representing the major forms of lung cancer. Cancer Res 52:5359-5363.
7. Chin YE, Kitagawa M, Su WC, You ZH, Iwamoto Y, Fu XY. 1996. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21/WAF1/CIP1 mediated by STAT1. Science 272:719-722.
8. Chrysogelos SA, Dickson RB. 1994. EGF receptor expression, regulation, and function in breast cancer. Breast Cancer Res Treat 29:29-40.
9. Clark E, Swank RA, Morgan JE, Basu H, Matthews HR. 1991. Two new photoaffinity polyamines appear to alter the helical twist of DNA in nucleosome core particles. Biochemistry 30:4009-4020.
10. Cochet C, Chambez EM. 1983. Polyamine-mediated protein phosphorylations. A possible target for intracellular polyamine action. Mol Cell Endocrinol 30:247-266.
11. Cohen S, Carpenter G, King L Jr. 1981. Epidermal growth factor receptor-protein kinase interactions. Prog Clin Biol Res 66:557-567.
12. Cohen FJ, Manni A, Glikman P, Bartholomew M, Demers L. 1988. Involvement of the polyamine pathway in antiestrogen-induced growth inhibition of human breast cancer. Cancer Res 48:6819-6825.
13. Daly J M, Jannot CB, Beerli RR., Graus-Porta D, Maurer FG, Hynes NE. 1997. Neu differentiation factor induces erbB2 down-regulation and apoptosis of erbB2-overexpressing breast tumor cells. Cancer Res 57:3804-3811.
14. 12-bis(ethyl)spermine. Cancer Res 53:2071-2075.
15. Desiderio MA, Grassilli E, Bellesia E, Salomoni P, Franceschi C. 1995. Involvement of ornithine decarboxylase and polyamines in glucocorticoid-induced apoptosis of rat thymocytes. Cell Growth Differ 6:505-513.
16. Dong X-F, Berthois Y, Martin PM. 1991. Effect of epidermal growth factor on the proliferation of human epithelial cell lines: correlation with the level of occupied EGF receptor. Anticancer Res 11:737-744.
17. Duke RC, Cohen JJ. 1986. IL-2 addiction: withdrawal of growth factor activates suicide program in dependent T cells. Lymphokine Res 5:289-299.
18. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
19. Faaland CA, Laskin JD, Thomas TJ. 1995. Inhibition of epidermal growth factor-stimulated EGF receptor tyrosine kinase activity in A431 human epidermoid carcinoma cells by polyamines. Cell Growth Differ 6:115-121.
20. Fan Z, Lu Y, Wu X, DeBlasio A, Koff A, Mendelsohn J. 1995. Prolonged induction of p21/Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition. J Cell Biol 131:235-242.
21. Filmus J, Pollak MN, Cailleau R, Buick RN. 1985. MDA-MB-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem Biophys Res Commun 128:898-905.
22. Fucile NW, Cooper E, Spaulding SW. 1984. Effects of cycloheximide, α-amanitin, and α-difluoromethylornithine on thyrotropin-induced increases in the micrococcal nuclease sensitivity of thyroid nuclear chromatin. Endocrinology 115:1705-1709.
23. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G. 1994. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54:1812-1817.
24. Gray-Bablin J, Zalvide J, Fox MP, Knickerbocker CJ, DeCaprio JA, Keyomarsi K. 1996. Cyclin E, a redundant cyclin in breast cancer. Proc Natl Acad Sci USA 93:15215-15220.
25. Gulli LF, Palmer KC, Chen YQ, Reddy KB. 1996. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity. Cell Growth Differ 7:173-178.
26. Harper JW, Adam GR, Wei N, Keyomarsi K, Elledge SJ. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
27. Hartwell LH, Kastan MB. 1994. Cell cycle control and cancer. Science 266:1821-1828.
28. Heby O, Persson L. 1990. Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem Sci 15:153-158.
29. Hunter T, Pines J. 1994. Cyclins and cancer. II: cyclin D and CDK inhibitors come of age. Cell 79:573-582.
30. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB. 1994. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54:380-385.
31. Kiyokawa N, Lee EK, Karunagaran D, Lin SY, Hung MC. 1997. Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor. J Biol Chem 272: 18656-18665.
32. Leroy D, Filhol O, Delcros JG, Pares S, Chambez EM, Cochet C. 1997. Chemical features of the protein kinase CK2-polyamine binding site. Biochemistry 36:1242-1250.
33. MacLeod CL, Luk A, Castagnola J, Cronin M, Mendelsohn J. 1986. EGF induces cell cycle arrest of A431 human epidermoid carcinoma cells. J Cell Physiol 127:175-182.
34. Manni A, Badger B, Wechter R, Kunselman S, Rossini A, Demers L. 1995. Biochemical and growth-modulatory effects of the new Sadenosylmethionine decarboxylase inhibitor CGP 48664 in malignant and immortalized normal human breast epithelial cells in culture. Int J Cancer 62:485-491.
35. Matsui I., Pegg AE. 1980. Effect of thioacetamide, growth hormone or partial hepatectomy on spermidine/spermine acetylase activity in rat liver. Biochem Biophys Res Commun 92:1009-1015.
36. Matthews HR. 1993. Polyamines, chromatin structure and transcription. Bioessays 15:561-566.
37. McCloskey DE, Casero RA Jr, Woster PM, Davidson NE. 1995. Induction of programmed cell death in human breast cancer cells by an unsymmetrically alkylated polyamine analogue. Cancer Res 55: 3233-3236.
38. Min A, Hasuma T, Yano Y, Matsui-Yuasa I, Otani S. 1995. Regulation of apoptosis of interleukin 2-dependent mouse T-cell line by protein tyrosine phosphorylation and polyamines. J Cell Physiol 165:615-623.
39. Musgrove EA, Hamilton JA, Lee CS, Sweeney KJ, Watts CKW, Sutherland RL. 1993. Growth factor, steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol 13:3577-3587.
40. Packham G, Cleveland JL. 1994. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol Cell Biol 14:5741-5747.
41. Packham G, Cleveland JL. 1995. The role of ornithine decarboxylase in c-Myc-induced apoptosis. Curr Top Microbiol Immunol 194:283-290.
42. Panagiotidis CA, Artandi S, Calame K, Silverstein SJ. 1995. Polyamines alter sequence-specific DNA-protein interactions. Nucleic Acids Res 23:1800-1809.
43. Pegg AE. 1988. Polyamine metabolism and its importance in neoplastic growth as a target for chemotherapy. Cancer Res 48:759-774.
44. Poulin R, Pelletier G, Pegg AE. 1995. Induction of apoptosis by excessive polyamine accumulation in ornithine decarboxylase-overproducing L1210 cells. Biochem J 311:723-727.
45. Prall OWJ, Sarcevic B, Musgrove EA, Watts CKW, Sutherland RL. 1997. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J Biol Chem 272:10882-10894.
46. Prasad KAN, Church JG. 1991. EGF-dependent growth inhibition in MDA-MB-468 human breast cancer cells is characterized by late G1 arrest and altered gene expression. Exp Cell Res 195:20-26.
47. Quantin B, Breathnach R. 1988. Epidermal growth factor stimulates transcription of the c-jun protooncogene in rat fibroblasts. Nature 334:538-539.
48. Reddy SG, McIlheran SM, Cochran BJ, Worth LL, Bishop LA, Brown PJ, Knutson VP, Haddox MK. 1996. Multisite phosphorylation of ornithine decarboxylase in transformed macrophages results in increased intracellular enzyme stability and catalytic efficiency. J Biol Chem 271:24945-24953.
49. Rusch V, Mendelsohn J, Dmitrovsky E. 1996. The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors. Cytokine Growth Factor Rev 7:133-141.
50. Scharerli P, Jaggi R. 1998. EGF-induced programmed cell death of human mammary carcinoma MDA-MB-468 cells is preceded by activation of AP-1. Cell Mol Life Sci 54:129-138.
51. Sherr CJ. 1996. Cancer cell cycles. Science 274:1672-1677.
52. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA. 1995. Cyclin D1 provides a link between development and oncogenesis in retina and breast. Cell 82:621-630.
53. Sieler N, Sarhan S, Grauffell C, Jones R, Knodgen B, Moulinoux J-P. 1990. Endogenous and exogenous polyamines in support of tumor growth. Cancer Res 50:5077-5083.
54. Snyder RD. 1989. Polyamine depletion is associated with altered chromatin structure in HeLa cells. Biochem J 260:697-704.
55. Stastny M, Cohen S. 1970. Epidermal growth factor: the induction of ornithine decarboxylase. Biochim Biophys Acta 204:578-589.
56. Tabor CW, Tabor H. 1984. Polyamines. Annu Rev Biochem 53:749-790.
57. Thomas T, Kiang DT. 1987. Additive growth-inhibitory effects of DL-adifluoromethylornithine and antiestrogens on MCF-7 breast cancer cell line. Biochem Biophys Res Commun 148:1338-1345.
58. Thomas T, Thomas TJ. 1994. Regulation of cyclin B1 by estradiol and polyamines in MCF-7 breast cancer cells. Cancer Res 54:1077-1084.
59. Thomas T, Thomas TJ. 1993. Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications. Breast Cancer Res Treat 29:189-201.
60. Thomas T, Trend B, Butterfield JR, Janne OA, Kiang DT. 1989. Regulation of ornithine decarboxylase gene expression in MCF-7 breast cancer cells by antiestrogens. Cancer Res 49:5852-5857.
61. Thomas T, Gallo MA, Klinge CM, Thomas TJ. 1995. Polyamine-mediated conformational perturbations in DNA alter the binding of estrogen receptor to poly(dG-m5dC). Poly(dG-m5dC) and a plasmid containing the estrogen response element. J Steroid Biochem Mol Biol 54:89-99.
62. Thomas T, Faaland CA, Adhikarakunnathu S, Thomas TJ. 1996. Structure-activity relations of S-adenosylmethionine decarboxylase inhibitors on the growth of MCF-7 breast cancer cells. Breast Cancer Res Treat 39:293-306.
63. Thomas TJ, Shah N, Faaland CA, Gallo MA, Yurkow E, Satyaswaroop PG, Thomas T. 1997. Effects of a bis(benzyl)spermine analog on MCF-7 breast cancer cells in culture and nude mice xenografts. Oncol Rep 4:5-13.
64. Thomas TJ, Faaland CA, Adhikarakunnathu SA, Watkins LF, Thomas T. 1998. Induction of p21 (CIP1/WAF1/SID1) by estradiol in a breast epithelial cell line transfected with the recombinant estrogen receptor gene: a possible mechanism for a negative regulatory role of estradiol. Breast Cancer Res Treat 47:181-193.
65. Van Agthoven T, van Agthoven TL, Dekker A, Foekens JA, Dorssers LC. 1994. Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations. Mol Endocrinol 8:1474-1483.
66. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671.
67. Wang JY, Viar MJ, Li J, Shi HJ, McCormack SA, Johnson LR. 1997. Polyamines are necessary for normal expression of the transforming growth factor-β gene during cell migration. Am J Physiol 272: G713-G720.
68. Watts CK, Brady A, Sarcevic B, deFazio A, Musgrove EA, Sutherland RL. 1995. Antiestrogen inhibition of cell cycle progression in breast cancer cells is associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. Mol Endocrinol 9:1804-1813.
69. Wuarin J, Nurse P. 1996. Regulating S phase: CDKs, licensing and proteolysis. Cell 85: 785-787.
70. Yarden RI, Lauber AH, El-Ashry D, Chrysogelos SA. 1996. Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells. Endocrinology 137:2739-2747.
71. You M, Zhao Z. 1997. Positive effects of SH2 domain-containing tyrosine phosphsphatase SHP-1 on epidermal growth factor- and interferon-γ-stimulated activation of STAT transcription factors in Hela cells. J Biol Chem 272:23376-23381.
72. Zamble DB, Jacks T, Lippard SJ. 1998. p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells. Proc Natl Acad Sci USA 95:6163-6168.
73. Zeng YX, El-Deiry WS. 1996. Regulation of p21WAF1/CIP1 expression by p53-independent pathways. Oncogene 12:1557-1564.